rhinovirusspecif
antibodi
tradit
detect
abil
neutralis
homolog
rhinoviru
serotyp
tissu
cultur
recent
howev
describ
enzymelink
immunosorb
assay
detect
rhinovirusspecif
antibodi
sera
nasal
secret
barclay
anakib
describ
evalu
elisa
studi
involv
adult
volunt
inocul
intranas
human
rhinoviru
type
preand
postinocul
serum
sampl
preinocul
nasal
wash
test
presenc
antibodi
elisa
antibodi
associ
protect
infect
present
local
nasal
secret
also
present
serum
associ
protect
infect
develop
ill
antibodi
concentr
show
strong
correl
antibodi
detect
neutralis
test
follow
infect
rise
iga
sera
detect
elisa
occur
frequent
rise
neutralis
antibodi
result
suggest
elisa
sensit
reliabl
indic
recent
infect
well
predictor
homolog
immun
statu
rhinovirus
major
caus
agent
common
cold
couch
earlier
studi
suggest
follow
infect
rhinoviru
serotypespecif
antibodi
appear
serum
nasal
secret
presenc
antibodi
confer
longterm
protect
reinfect
homolog
rhinoviru
serotyp
doggett
antibodi
tradit
detect
neutralis
test
hamparian
recent
howev
establish
sensit
enzymelink
immunosorb
assay
detect
rhinovirusspecif
antibodi
sera
unconcentr
nasal
wash
new
assay
simpl
rapid
differenti
class
rhinovirusspecif
immunoglobulin
preliminari
studi
involv
volunt
inocul
intranas
human
rhinoviru
el
hrvel
show
presenc
circul
rhinovirusspecif
iga
rather
igg
protect
volunt
infect
barclay
alnakib
present
studi
describ
extens
analysi
antihuman
rhinoviru
type
immunoglobulin
respons
sera
nasal
wash
measur
elisa
thu
volunt
inocul
intranas
cours
infect
monitor
clinic
virolog
data
confirm
import
iga
antirhinoviru
immunoglobulin
protect
reinfect
andor
ill
provid
evid
rise
specif
serum
iga
follow
infect
good
indic
recent
infect
sampl
obtain
volunt
take
part
separ
studi
test
therapeut
effect
zinc
glucon
lozeng
cold
caus
alnakib
et
al
hous
isol
accord
standard
procedur
common
cold
unit
bear
reed
serum
sampl
collect
trial
week
rhinoviru
inocul
store
nasal
wash
antibodi
measur
collect
trial
instil
ml
phosphatebuff
salin
pb
nostril
volunt
forcibl
expel
liquid
pot
contain
glass
bead
vortex
sec
break
mucu
effluent
centrifug
rpm
microcentrifug
supernat
store
nasal
wash
viru
isol
taken
day
inocul
use
standard
method
barclay
alnalub
ad
equal
volum
nutrient
broth
store
virus
isol
inocul
ohio
hela
cell
sampl
ml
nasal
wash
inocul
confluent
test
tube
cultur
roll
day
examin
presenc
viru
cytopath
effect
cpe
cold
assess
combin
tissu
count
subject
object
evalu
sever
symptom
clinic
score
bear
reed
basi
viru
isol
criteria
volunt
divid
three
group
analysi
follow
cold
group
viru
isol
clinic
cold
subclin
infect
group
viru
isol
cold
infect
group
viru
isol
cold
human
rhinoviru
type
grown
ohio
hela
cell
crude
antigen
prepar
made
previous
describ
hrvel
barclay
alnakib
control
antigen
prepar
way
uninfect
monolay
fifti
millilitr
crude
antigen
titr
approxim
concentr
ultracentrifug
resuspend
viru
pellet
ml
pb
ml
antigen
emulsifi
equal
volum
freund
complet
adjuv
fca
use
inocul
one
rabbit
subcutan
six
week
later
rabbit
inocul
intramuscularli
emuls
ml
ml
freund
incomplet
adjuv
fica
fourteen
day
later
anim
bled
result
hyperimmun
serum
neutralis
titr
tcidso
store
elisa
hrvzspecif
immunoglobulin
sera
nasal
secret
adapt
previous
describ
hrvelspecif
immunoglobulin
barclay
alnakib
polystyren
roundbottom
micro
elisa
plate
nunc
immunopl
u
type
incub
overnight
pl
per
well
ooo
dilut
rabbit
hyperimmun
serum
carbonatebicarbon
buffer
ph
well
drain
wash
three
time
pb
contain
tween
pbst
pl
control
antigen
cag
dilut
pbst
contain
bovin
serum
albumin
bsa
ad
altern
row
well
plate
incub
hr
c
drain
wash
one
hundr
microlitr
standard
test
sampl
dilut
pbst
contain
bsa
cag
ad
duplic
cagcoat
well
standard
pool
known
sera
nasal
wash
titrat
plate
onehalf
loglo
dilut
step
sampl
dilut
respect
assay
specif
iga
igg
sera
detect
specif
iga
nasal
wash
plate
incub
hr
wash
either
antihuman
iga
alkalin
phosphatas
conjug
sigma
antihuman
igg
alkalin
phosphatas
conjug
icn
ad
dilut
ooo
pbst
bsa
incub
overnight
plate
final
wash
four
time
pbst
substrat
sigma
pnitrophenol
phosphat
tablet
dissolv
mgml
diethanolamin
buffer
ad
well
plate
incub
hr
optic
densiti
od
nm
read
dynatech
elisa
reader
use
refer
filter
nm
mean
od
duplic
well
correct
subtract
mean
od
cagcoat
well
serum
standard
arbitrarili
allot
loglo
unit
nasal
wash
standard
loglo
unit
use
correct
od
titrat
elisa
plate
standard
curv
calcul
correct
od
sampl
read
standard
curv
thu
sampl
award
number
loglo
unit
relat
known
standard
antibodi
unit
specif
iga
nasal
wash
correct
normalis
total
iga
sampl
elisa
total
iga
nasal
wash
perform
previous
describ
callow
normalis
result
signific
differ
specif
iga
concentr
nasal
secret
three
group
establish
size
signific
rise
antibodi
follow
infect
pair
sera
volunt
receiv
intranas
inocul
salin
viru
hous
isol
exactli
volunt
test
antibodi
signific
rise
antibodi
set
mean
differ
pair
sera
plu
sd
mean
thu
signific
rise
elisa
iga
sera
differ
loglo
unit
igg
serumspecif
antibodi
valu
log
lo
unit
rise
antibodi
consid
signific
differ
fourfold
ie
loglo
step
greater
neutralis
antibodi
sera
detect
microneutralis
test
challeng
tcidso
homolog
rhinoviru
previous
describ
barclay
alnakib
statist
analys
perform
ibm
xt
comput
use
programm
statist
packag
person
comput
spp
patrick
royston
clinic
research
centr
northwick
park
hospit
harrow
england
compar
frequenc
antibodi
rise
three
volunt
group
test
use
yate
correct
examin
signific
differ
antibodi
concentr
group
rank
analysi
varianc
use
compar
antibodi
concentr
differ
type
magnitud
antibodi
rise
spearman
rank
correl
coeffici
calcul
volunt
intranas
inocul
cold
subclin
infect
becom
infect
figur
show
mean
antibodi
b
specif
igg
c
iga
serum
specif
iga
nasal
secret
normal
total
iga
preinocul
sampl
three
group
volunt
presenc
antibodi
serum
appear
confer
protect
infect
symptom
thu
volunt
get
infect
antibodi
sera
iga
igg
antibodi
subclin
infect
infect
develop
cold
develop
cold
lowest
amount
hrvzspecif
antibodi
sera
differ
amount
hrvzspecif
serum
antibodi
three
group
highli
signific
elisaspecif
iga
neutralis
antibodi
p
ool
signific
elisaspecif
igg
volunt
volunt
divid
three
group
accord
subsequ
respons
inocul
describ
text
infect
significantli
iga
preinocul
nasal
wash
becam
infect
whether
cold
howev
differ
concentr
antibodi
three
group
consid
individu
cold
group
subclin
infect
group
signific
therefor
although
presenc
local
specif
antibodi
appear
protect
infect
appear
prevent
ill
caus
infect
tabl
show
number
volunt
three
group
signific
rise
serum
antibodi
follow
intranas
inocul
frequenc
rise
neutralis
antibodi
elisaserumspecif
iga
significantli
differ
three
group
p
proport
rise
highest
cold
group
least
infect
group
differ
frequenc
rise
specif
igg
three
group
significantli
differ
thirtysix
volunt
show
rise
elisaserumspecif
iga
neutralis
antibodi
two
volunt
show
rise
neutralis
elisa
contrast
nine
volunt
show
rise
elisa
neutralis
tabl
thu
rise
elisaserumspecif
iga
slightli
frequent
neutralis
antibodi
vs
suggest
former
might
sensit
test
detect
rise
concentr
variou
antibodi
test
correl
size
antibodi
rise
substanti
correl
found
concentr
serum
antibodi
rise
antibodi
shown
figur
gener
presenc
rise
neutralis
elisa
serum
igg
iga
antibodi
significantli
associ
presenc
rise
rhinovirusspecif
antibodi
also
posit
correl
p
presenc
iga
nasal
secret
serum
addit
neg
correl
found
concentr
specif
iga
nasal
secret
size
rise
specif
iga
serum
p
ol
fig
thu
volunt
low
amount
preinocul
iga
nasal
secret
like
show
signific
rise
serumspecif
iga
similarli
also
neg
correl
concentr
specif
iga
preinocul
sera
rise
rhinovirusneutralis
antibodi
vice
versa
p
ool
suggest
low
specif
iga
neutralis
antibodi
concentr
preinocul
sera
associ
subsequ
larg
rise
neutralis
antibodi
specif
iga
follow
inocul
found
signific
associ
presenc
neutralis
antibodi
elisaserumspecif
iga
protect
reinfect
ill
thu
volunt
high
level
hrvzspecif
iga
neutralis
antibodi
sera
get
infect
develop
symptom
cold
inocul
contrast
lower
level
specif
iga
neutralis
antibodi
subclin
infect
littl
antibodi
becam
infect
develop
cold
interestingli
presenc
iga
nasal
secret
associ
protect
infect
ill
find
gener
agreement
anoth
viru
caus
common
coldscoronaviru
callow
howev
studi
serumspecif
igg
appear
least
effect
prevent
infect
diseas
serumspecif
iga
furthermor
coronavirusspecif
iga
nasal
secret
significantli
shorten
period
viru
shed
also
appear
reduc
symptom
recent
similar
studi
involv
sampl
obtain
volunt
inocul
anoth
rhinoviru
serotyp
test
elisa
homolog
antibodi
appear
confirm
associ
elisaserumspecif
iga
protect
reinfect
callow
sergeant
unpublish
data
standard
serolog
test
recent
rhinoviru
infect
detect
rise
neutralis
antibodi
studi
show
rise
circul
rhinovirusspecif
iga
least
reliabl
purpos
fact
present
elisa
detect
rise
iga
three
subclin
infect
four
uninfect
volunt
whose
sera
neutralis
test
fail
detect
rise
elisa
antibodi
rise
may
fals
sinc
uninfect
volunt
excret
viru
separ
studi
laboratori
howev
sever
nasal
wash
volunt
viru
isol
ie
infect
group
contain
antigen
detect
biotidstreptavidin
bridg
elisa
system
thu
although
excret
infecti
viru
could
isol
ohio
hela
cell
activ
produc
viral
antigen
suggest
viral
replic
may
take
place
size
rise
iga
serum
viru
inocul
show
signific
neg
correl
concentr
specif
iga
preinocul
nasal
secret
presenc
serum
neutralis
antibodi
indic
volunt
suscept
infect
ill
fact
show
largest
antibodi
respons
small
number
serumspecif
igg
rise
detect
elisa
weak
correl
presenc
preinocul
igg
protect
reinfect
might
explain
fact
gener
elisa
detect
larg
amount
specif
igg
volunt
preinocul
sera
far
test
suggest
previous
may
due
use
crude
tissu
cultur
fluid
harvest
antigen
elisa
contain
mixtur
bothjkll
nativ
viru
particl
empti
capsid
latter
shown
crossreact
antisera
heterolog
serotyp
lonbergholm
yin
thu
igg
persist
previou
infect
rhinoviru
serotyp
could
crossreact
elisa
recent
obtain
evid
purif
homotyp
full
viru
particl
sucros
densiti
gradient
use
antigen
assay
improv
specif
test
barclay
unpublish
data
crossreact
appear
problem
iga
classspecif
conjug
use
presum
iga
antibodi
respons
short
durat
persist
long
igg
class
conclus
elisa
describ
studi
accur
predictor
jmmune
statu
individu
homolog
rhinoviru
reliabl
diagnost
assay
detect
recent
rhinoviru
infect
measur
signific
rise
specif
iga
thu
could
use
evalu
efficaci
novel
rhinoviru
vaccin
antivir
compound
futur
measur
incid
infect
follow
challeng
homolog
viru
studi
possibl
elisa
system
modifi
detect
rise
rhinoviru
serotyp
